Subcutaneous tocilizumab may be less effective than intravenous tocilizumab in the treatment of juvenile idiopathic arthritis-Associated uveitis

  1. Quesada-Masachs, E.
  2. Caballero, C.M.
Journal:
Journal of Rheumatology

ISSN: 1499-2752,  0315-162X

Year of publication: 2017

Volume: 44

Issue: 2

Pages: 260-261

Type: Letter

DOI: 10.3899/JRHEUM.160908 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus